OmniComm Introduces TrialOne: An Integrated Suite of Web Based Solutions for Phase I Clinic Automation and Management
OmniComm Systems, Inc. (OTC: OMCM.OB), a global provider of eClinical solutions announced that it released TrialOne, a fully integrated, MS .NET, web‐based solution designed to automate the Phase I Clinical Trial Process. TrialOne provides web‐based tools used to recruit study volunteers, schedule screening appointments, collect screening data, directly capture real‐time data, track sample transfers and address the unique requirements of early phase studies. Within each study, real‐time electronic data is captured and validated at the subject’s bedside or at a subject queuing station. Enhanced workflow technology automates sample processing throughout the lab. TrialOne supports a myriad of directly attached biomedical monitoring devices such as the GE Healthcare DINAMAP® family of vital signs monitors and various ECG devices.
TrialOne enables Phase I Clinics to share data with other stakeholders via the internet and provides a flexible ad‐hoc reporting tool to help export and report data in various formats including Adobe® PDF, Microsoft® Excel and Word. Further extensibility of the TrialOne suite via integration to our flagship EDC product, TrialMaster®, using OmniConnect™, our enhanced web services API, and an integrated pharmacy module is planned for release later this year.
“TrialOne is the only available product that handles all aspects of the Phase I process from subject recruitment and clinical wokflow management to laboratory sample management,” said OmniComm’s CTO, Randy Smith.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
